ACKR3 and Huntington disease: CD19+/CD38hi/CD24hi/CXCR7+/IL-10+ B cell percentages were comparable in HD and ELTGF patients; nonetheless the latter two groups had ≅42% higher levels versus CGD patients (P ≤ 0.04; Figures 3(g)–3(l), and 3(r), Table 2).